-
Mallinckrodt (MNK) and Endo (NDOI) Announce Planned Leadership Team for Merged Company
-
Mallinckrodt, Endo Announce Planned Leadership Team for Merged Company
-
Mallinckrodt and Endo Announce Significant Progress in Proposed Merger
-
Endo Reports First-Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance
-
BWS Financial Starts Endo Pharma (NDOI) at Buy
-
Mallinckrodt (MNK) and Endo (NDOI) to Combine
-
Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
-
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
-
Endo Reports Third-Quarter 2024 Financial Results and Reaffirms 2024 Financial Expectations
-
ENDO ANNOUNCES CEO TRANSITION
-
ENDO REPORTS SECOND-QUARTER 2024 FINANCIAL RESULTS
-
Endo Releases Annual Corporate Responsibility Report

